Publications by authors named "Sooyun C Tavolacci"
The emerging ex vivo machine perfusion (MP) enables the extension of ex situ intervals, potentially expanding the heart transplant (OHT) donor pool. From October 18, 2018, to June 30, 2023, isolated OHT using donation after brain death (DBD) from extended distances (>500 miles) were identified in the United Network for Organ Sharing database, and categorized into cold storage (non-MP, N = 1,212) and MP group (N = 152). The MP utilization rate for DBD hearts from extended distances surged from 0% in 2018 to 27.
View Article and Find Full Text PDFIntroduction: There is a lack of evidence regarding the impact of donor blood transfusion on heart transplant (HT) outcomes. We sought to elucidate the influence of donor transfusion on HT outcomes using the national database.
Methods: From January 2004 to March 2023, donor transfusion information was available for 40 538 recipients for HT in the United Network for Organ Sharing (UNOS) database.
Emergency trans-mitral septal myectomy with resection of abnormal papillary muscles.
Multimed Man Cardiothorac Surg
November 2024
Article Synopsis
- A 70-year-old woman with a history of heart issues underwent elective alcohol septal ablation but developed severe complications during the procedure, including cardiogenic shock and pulmonary edema that necessitated intubation.
- Emergency surgery revealed abnormal papillary muscles contributing to left ventricular outflow tract obstruction, which were subsequently removed along with other cardiac repairs.
- Post-surgery, the patient's heart function improved and the complications highlighted challenges in diagnosing anomalous cardiac structures before surgery.
Background: The Impella 5.5® is commonly inserted via the axillary artery (AX) in patients with cardiogenic shock. The right AX has traditionally been preferred to avoid crossing the aortic arch, and a minimum diameter of 7 mm has been recommended to accommodate the device (21 Fr).
View Article and Find Full Text PDFArticle Synopsis
- SARS-CoV-2 can spread from asymptomatic individuals, posing a greater risk to cancer patients who frequently visit healthcare facilities and are more vulnerable to severe COVID-19 outcomes.* -
- A study of lung cancer patients revealed that over half of those with evidence of SARS-CoV-2 infection were asymptomatic at diagnosis, and a significant number were never clinically diagnosed.* -
- The findings indicate that older patients and those with early-stage lung cancer are more likely to have asymptomatic infections, highlighting the need for continued preventive measures in high-risk populations.*
Article Synopsis
- * Data from 6,927 patients were analyzed using a prediction model, identifying serum values, demographics, and comorbidities as key predictors for in-hospital mortality and AA onset.
- * The study found that potassium levels, among other biomarkers, could serve as independent prognostic indicators, with specific increases linked to heightened risks of mortality and arrhythmias.
Patients diagnosed with lung cancer (LC) exhibit increased susceptibility to SARS-CoV-2 infection. Rodilla et al. monitor the levels of plasma anti-nucleocapsid antibodies within a cohort of fully vaccinated LC patients and reveal that the actual infection rate is nearly twice the documented rate, indicating a significant prevalence of unreported cases.
View Article and Find Full Text PDF